September 2026
The brain health supplements and therapeutics market size was USD 20.42 billion in 2026, with leading brain health supplements and therapeutics market players including Neuriva, Prevagen, Danone, Nestlé Health Science.
September 2026
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 17.03 billion in 2026, with a CAGR of 7.02%.
September 2026
The mRNA vaccines and therapeutics market size reached USD 130.20Â billion in 2026 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
September 2026
The personalized testing and supplements market size reached USD 5.61 billion in 2026, with leading personalized testing and supplements market companies including Viome Life Sciences, DSM Nutritional Products AG.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The global pet food and supplements market size is expected to be hit around USD 200.39 billion by 2034 from USD 130.57 billion in 2026 with a CAGR of 5.5%.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
July 2026
The digital therapeutics and connected care market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
March 2026
The global allergy diagnostics and therapeutics market size is expected to hit around USD 75.07 billion by 2035 from USD 38.76 billion in 2025 with a CAGR of 6.83%.
January 2026
The bone and joint health supplements market size surpassed USD 4.74 billion in 2025 and is predicted to hit around USD 9.40 billion by 2035 with a CAGR of 7.09%.
September 2026
The Europe urinary incontinence therapeutics market was valued at USD 11.77 billion in 2025 and is expected to expand at a CAGR of 3.15% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The global amyloidosis therapeutics market size was valued at USD 3.44 billion in 2026 and is expected to hit around 6.92 billion by 2035, growing at a CAGR of 8.09% from 2026 to 2035.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The global sleep aid supplements market size expected to increase from at USD 7.95 billion in 2026 and is predicted to hit USD 12.46 billion by 2035, growing at a CAGR of 5.11%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global testosterone booster supplements market size was evaluated at USD 4.22 billion in 2026 and is predicted to hit around USD 10.32 billion by 2035, growing at a CAGR of 10.45%.
September 2026
The microbiome therapeutics market size reached USD 334.16 million in 2026, with leading microbiome therapeutics market companies including Seres Therapeutics, Nestlé Health Science, Finch Therapeutics.
September 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The global wellness supplements market size is expected to increase from USD 313.49 million in 2026 to hit around USD 607.61 million by 2035, with a CAGR of 7.64%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The mRNA therapeutics market size was valued at USD 22.30 billion in 2026 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
September 2026
The global fertility supplements market size is projected to surpass around USD 5.19 billion by 2035 increasing from USD 2.61 billion in 2026, with a CAGR of 7.93%.
September 2026
The global lactation support supplements market size and is projected to hit around USD 1554.70 million by 2035 from USD 818.20 million in 2026 with CAGR of 7.39%.
September 2026
The global scleroderma therapeutics market size is projected to surpass around USD 4.48 billion by 2035 increasing from USD 2.88 billion in 2026, with a CAGR of 5.04%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com